Thomas Jay Lowery
Chief Tech/Sci/R&D Officer at Satellite Biosciences, Inc.
Profile
Thomas Jay Lowery is currently the Chief Technology Officer at Satellite Biosciences, Inc. Previously, he worked as the Vice President-Diagnostics Research & Development at T2 Biosystems, Inc. He received his undergraduate degree from Brigham Young University and his doctorate from the University of California, Berkeley.
Thomas Jay Lowery active positions
Companies | Position | Start |
---|---|---|
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Chief Tech/Sci/R&D Officer | 2020-07-31 |
Former positions of Thomas Jay Lowery
Companies | Position | End |
---|---|---|
T2 BIOSYSTEMS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Thomas Jay Lowery
Brigham Young University | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
T2 BIOSYSTEMS, INC. | Health Technology |
Private companies | 1 |
---|---|
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Health Technology |
- Stock Market
- Insiders
- Thomas Jay Lowery